153 related articles for article (PubMed ID: 23879964)
1. Next generation analysis of breast cancer genomes for precision medicine.
Previati M; Manfrini M; Galasso M; Zerbinati C; Palatini J; Gasparini P; Volinia S
Cancer Lett; 2013 Oct; 339(1):1-7. PubMed ID: 23879964
[TBL] [Abstract][Full Text] [Related]
2. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.
Roukos DH
Pharmacogenomics J; 2011 Apr; 11(2):81-92. PubMed ID: 20975737
[TBL] [Abstract][Full Text] [Related]
4. Cancer epigenomics: beyond genomics.
Sandoval J; Esteller M
Curr Opin Genet Dev; 2012 Feb; 22(1):50-5. PubMed ID: 22402447
[TBL] [Abstract][Full Text] [Related]
5. [Genomics and clinical research for breast cancer].
Bertucci F; Birnbaum D
Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
[TBL] [Abstract][Full Text] [Related]
6. [Human genome sequencing--next generation technology or will the routine sequencing of human genome be possible?].
Pospísilová S; Tichý B; Mayer J
Cas Lek Cesk; 2009; 148(7):296-302. PubMed ID: 19642294
[TBL] [Abstract][Full Text] [Related]
7. The Cancer Genome Atlas: clinical applications for breast cancer.
Ma CX; Ellis MJ
Oncology (Williston Park); 2013 Dec; 27(12):1263-9, 1274-9. PubMed ID: 24624545
[TBL] [Abstract][Full Text] [Related]
8. What to expect from high throughput genomics in metastatic breast cancers?
Onesti CE; Vicier C; André F
Breast; 2015 Nov; 24 Suppl 2():S19-22. PubMed ID: 26238439
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in molecular genetics of breast cancer.
Pavelić K; Gall-Troselj K
J Mol Med (Berl); 2001 Oct; 79(10):566-73. PubMed ID: 11692153
[TBL] [Abstract][Full Text] [Related]
10. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
Cloonan N; Waddell N; Grimmond SM
IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
[TBL] [Abstract][Full Text] [Related]
11. Genomics and epigenomics: new promises of personalized medicine for cancer patients.
Schweiger MR; Barmeyer C; Timmermann B
Brief Funct Genomics; 2013 Sep; 12(5):411-21. PubMed ID: 23814132
[TBL] [Abstract][Full Text] [Related]
12. Translating cancer genomes sequencing revolution into surgical oncology practice.
Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.
Boerno ST; Grimm C; Lehrach H; Schweiger MR
Epigenomics; 2010 Apr; 2(2):199-207. PubMed ID: 22121870
[TBL] [Abstract][Full Text] [Related]
14. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.
Veeraraghavan J; Ma J; Hu Y; Wang XS
Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070
[TBL] [Abstract][Full Text] [Related]
15. Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.
Simpson PT; Vargas AC; Al-Ejeh F; Khanna KK; Chenevix-Trench G; Lakhani SR
Hum Pathol; 2011 Feb; 42(2):153-65. PubMed ID: 21106225
[TBL] [Abstract][Full Text] [Related]
16. [Cancer genome analysis through next-generation sequencing].
Aburatani H
Gan To Kagaku Ryoho; 2011 Jan; 38(1):1-6. PubMed ID: 21368453
[TBL] [Abstract][Full Text] [Related]
17. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
18. Research and clinical applications of cancer genome sequencing.
Ku CS; Cooper DN; Ziogas DE; Halkia E; Tzaphlidou M; Roukos DH
Curr Opin Obstet Gynecol; 2013 Feb; 25(1):3-10. PubMed ID: 23108289
[TBL] [Abstract][Full Text] [Related]
19. Whole cancer genome sequencing by next-generation methods.
Ross JS; Cronin M
Am J Clin Pathol; 2011 Oct; 136(4):527-39. PubMed ID: 21917674
[TBL] [Abstract][Full Text] [Related]
20. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.
Schweiger MR; Kerick M; Timmermann B; Isau M
Cancer Metastasis Rev; 2011 Jun; 30(2):199-210. PubMed ID: 21267768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
